Unlock the potential of Single Cell Metabolic Analysis

Gammaomics™ holds the exclusive global license for SCENITH™, the technology that unveils cellular metabolism with unprecedented precision, driving personalized medicine and cutting-edge research.

Single cell resolution for complex immuno-metabolic profiling
Fast. Reliable. Trustworthy.

Don’t settle for incomplete data.
Your research deserves better.

Conventional techniques to study cellular metabolism require large cell numbers, expensive specialized equipment, and complex steps that disrupt the natural cellular environment.
The result: unreliable or non-comparable data, failed experiments, and weeks of wasted time and resources.

Robust, accessible, and fully compatible with your samples.

Why SCENITH™

Single cell resolution for complex immuno-metabolic profiling.
Compatible with flow cytometry.
Minimal cell input, maximum insight (Requires small number of cells compared to other methods).

Single Cell

Our SCENITH™ technology provides single-cell resolution, allowing researchers to study rare cells and compare metabolic profiles with ease.

Multiple Applications

Immunology, oncology, Allergy, Aging, CAR-T cells, Metabolic Disorders and many more.

R&D Direction

Pushing the boundaries of SCENITH™ applications, working to integrate SCENITH™ with spatial and sequencing technologies, and to create large panels of metabolic inhibitors for comprehensive metabolomic profiling.

SCENITH™ By Flow-cytometry

Experience the power of SCENITH™ for flow cytometry. Our SCENITH™ Flow product offers a robust, flow-based alternative to traditional metabolic assays, providing consistent and reproducible results at single-cell resolution.

Research Use Only (RUO) Services

We offer a range of RUO services, including after-sales advisory, product and protocol troubleshooting, and training seminars, ensuring you have the support you need to maximize the potential of our innovative technologies.

SCENITH™ in 4 Simple Steps

1

Prepare your sample.
Work with your cells directly in media.

2

Treat with metabolic inhibitors.
Flexible, customizable panels to probe glucose oxidation, mitochondrial respiration, and translation.

3

Run the samples through the cytometer. Rapid acquisition for single-cell resolution.

4

Analyze and compare. Clear, reproducible results with quantitative metabolic readouts. (Results in hours, not weeks).

No Cell Isolation required.

Compatible with human, non-human primate, and murine samples.

Provides comparable profiles across conditions and laboratories.

From order to first results in just a few days.
Ready-to-ship kits, optimized protocols, and fast international delivery.

RELIED UPON BY TOP RESEARCH INSTITUTIONS ACROSS THE GLOBE.

Over 600 labs worldwide use SCENITH™. Featured in 40+ publications, including Nature, Science Immunology, and Nature Communications.

Customers

Testimonials

ABOUT GAMMAOMICS
Based in Marseille, France, GammaOmics™ is the sole worldwide provider of SCENITH™, developed by Dr. Rafael Argüello and colleagues, with Dr. Argüello leading the invention of the method. We focus on cutting-edge single-cell technologies, delivering accessible tools that uncover complex immuno-metabolic profiles. With SCENITH™, researchers gain reliable, user-friendly insights that are shaping the future of personalized medicine.

Vision

Develop and provide personalized medicine tools to improve treatment efficacy.

Mission

Become a key player in the field of personalized medicine. Save more lives.

Supported by